Circadian modulation of human erythrocyte plasma membrane redox system by melatonin

详细信息	查看全文 | 推荐本文 |

• 作者：Shilpa Chakravarty ; Syed Ibrahim Rizvi ; ^{sirizvi@gmail.com}
• 关键词：Erythrocyte ; Melatonin ; Plasma membrane redox system ; Ascorbate free radical reductase
• 刊名：Neuroscience Letters
• 出版年：2012
• 期刊代码：52_03043940
• 类别：neu
• 出版时间：14 June, 2012
• 卷：518
• 期：1
• 页码：32-35
• 文件大小：368 K

摘要

Background

The pineal hormone melatonin works for the stabilization of biological rhythms, however, it also modulates several other functions such as cardioprotection, thermoregulation and immunomodulation. Melatonin also shows antioxidant activity. The erythrocyte plasma membrane redox system (PMRS) alongwith ascorbate free radical (AFR) reductase is involved in providing protection against oxidative stress. The present work is an ex vivo study addressing RBC PMRS and AFR reductase activities at two different times of the day. The in vitro modulatory effect of melatonin on PMRS and AFR reductase activities is also reported.

Materials and methods

The study was carried out on 61 healthy donors of both sexes (aged 20-30). Blood samples were collected at two different timings viz., 10:00 a.m. and 10:00 p.m. PMRS and AFR reductase were determined by methods already reported. The concentration-dependent effect of the melatonin was evaluated by incubating the RBCs with the hormone at different doses.

Results

We present results to show that erythrocyte PMRS and AFR reductase activity are modulated by melatonin, a higher activity (p < 0.05) of PMRS and AFR reductase is observed during night when the level of melatonin is high. The effect of in vitro treatment of erythrocytes with melatonin (10^鈭? M to 10^鈭?1 M final concentration) shows significant changes during day at a melatonin concentration of 10^鈭? M.

Conclusion

To the best of our knowledge this study shows for the first time the circadian rhythmicity of erythrocyte PMRS and AFR reductase activities. The modulatory effect of melatonin on PMRS and AFR reductase opens the possibility of melatonin being used in treatment of such physiological and metabolic dysfunctions that involve photic cues in association with oxidative stress.